We are live on ! Find out more
ECM

Endurant Capital Management Portfolio holdings

AUM $17.4M
1-Year Est. Return 7.38%
This Fund
S&P 500
This Quarter Est. Return
+5.47%
1 Year Est. Return
+7.38%
3 Year Est. Return
+18.38%
5 Year Est. Return
+100.61%
10 Year Est. Return
–
AUM
$299M
AUM Growth
-$9.51M
Cap. Flow
-$30.5M
Cap. Flow %
-10.19%
Top 10 Hldgs %
42.64%
Holding
104
New
18
Increased
30
Reduced
39
Closed
16

Top Buys

Rank Stock Value
1
ABT icon
Abbott
ABT
+$11.4M
2
AGN
Allergan plc
AGN
+$10.5M
3
WMGI
Wright Medical Group Inc
WMGI
+$8.41M
4
SHPG
Shire pic
SHPG
+$6.98M
5
MCK icon
McKesson
MCK
+$4.79M

Top Sells

Rank Stock Value
1
HRC
HILL-ROM HOLDINGS, INC.
HRC
+$8.16M
2
EVHC
Envision Healthcare Holdings Inc
EVHC
+$7.43M
3
ZBH icon
Zimmer Biomet
ZBH
+$7.17M
4
BXLT
BAXALTA INC COM STK (DE)
BXLT
+$7.08M
5
MDT icon
Medtronic
MDT
+$5.39M

Sector Composition

Rank Sector Weight
1 Healthcare 88.92%
2 Financials 3.84%
3 Industrials 1.57%
4 Energy 1.04%
5 Technology 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCR
76
DELISTED
CR Bard Inc.
BCR
$380K 0.13%
1,618
-7,882
-83% -$1.71M
PCRX icon
77
Pacira BioSciences
PCRX
$1.04B
$354K 0.12%
+10,500
New +$516K
HUM icon
78
Humana
HUM
$43.7B
$323K 0.11%
1,798
-2,100
-54% -$373K
CSLT
79
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$307K 0.1%
77,558
-50,046
-39% -$196K
ALPN
80
DELISTED
Alpine Immune Sciences Inc
ALPN
$303K 0.1%
16,446
+8,700
+112% +$154K
RDUS
81
DELISTED
Radius Health, Inc.
RDUS
$301K 0.1%
+8,200
New +$290K
ARA
82
DELISTED
American Renal Associates Holdings, Inc
ARA
$246K 0.08%
+8,500
New +$237K
TRIL
83
DELISTED
Trillium Therapeutics Inc.
TRIL
$245K 0.08%
27,300
+14,800
+118% +$154K
ALDR
84
DELISTED
Alder Biopharmaceuticals
ALDR
$245K 0.08%
+9,800
New +$265K
PMC
85
DELISTED
PharMerica Corporation
PMC
$232K 0.08%
9,390
-90,100
-91% -$2.24M
OCRX
86
DELISTED
Ocera Therapeutics, Inc.
OCRX
$196K 0.07%
103,142
-33,951
-25% -$89.3K
RXDX
87
DELISTED
Ignyta, Inc.
RXDX
$109K 0.04%
+20,200
New +$134K
ABBV icon
88
AbbVie
ABBV
$443B
– –
-6,700
Closed -$383K
CAH icon
89
Cardinal Health
CAH
$53.9B
– –
-5,200
Closed -$426K
CNMD icon
90
CONMED
CNMD
$1.39B
– –
-28,090
Closed -$1.18M
GMED icon
91
Globus Medical
GMED
$10.7B
– –
-65,700
Closed -$1.56M
MDT icon
92
Medtronic
MDT
$109B
– –
-71,866
Closed -$5.39M
MRK icon
93
Merck
MRK
$322B
– –
-10,590
Closed -$535K
ZVRA icon
94
Zevra Therapeutics
ZVRA
$562M
– –
-10,599
Closed -$2.46M
XENT
95
DELISTED
Intersect ENT, Inc
XENT
– –
-12,000
Closed -$228K
DPLO
96
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
– –
-13,800
Closed -$378K
ONCE
97
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
– –
-17,500
Closed -$516K
NXTM
98
DELISTED
NxStage Medical Inc.
NXTM
– –
-26,400
Closed -$396K
KTWO
99
DELISTED
K2M Group Holdings, Inc
KTWO
– –
-127,300
Closed -$1.89M
ZLTQ
100
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
– –
-9,100
Closed -$247K
1 2 3
4
5

Similar funds

VAFP
Vahanian & Associates Financial Planning Saratoga Springs, New York $25.3M AUM 39.42% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
SCM
Somerset Capital Management London, United Kingdom $8.12M AUM 21.3% 1-Year Est. Return
FWM
Fiat Wealth Management Wayzata, Minnesota $7.9M AUM
TOPU
Trustees of Princeton University Princeton, New Jersey $7.77M AUM
CCMU
Cheyne Capital Management (UK) London, United Kingdom $27.9M AUM 36.14% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
HSCU
Half Sky Capital (UK) London, United Kingdom $30.5M AUM 67.32% 1-Year Est. Return

Endurant Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Endurant Capital Management held 104 positions worth $299M, down 3.1% from $309M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Endurant Capital Management withdrew a net $30.5M in Q2 2016, closing 16 positions and reducing 39 holdings. Its most notable exit was BAXALTA INC COM STK (DE), an estimated $7.08M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 84% a quarter earlier, followed by Financials and Industrials.

Against the trend, Endurant Capital Management opened a new position in Cencora worth $3.85M.

  • Endurant Capital Management's largest Q2 2016 buy was Cencora: 48,600 shares worth $3.85M.
  • Endurant Capital Management added most to Abbott in Q2 2016, an estimated $11.4M increase.
  • Endurant Capital Management's biggest Q2 2016 reduction was HILL-ROM HOLDINGS, INC., cutting an estimated $8.16M.
  • Endurant Capital Management fully exited BAXALTA INC COM STK (DE) in Q2 2016, selling an estimated $7.08M.
  • Endurant Capital Management's ten largest holdings make up 43% of its $299M portfolio in Q2 2016.
  • Endurant Capital Management opened 18 new positions and closed 16 in Q2 2016.
  • Endurant Capital Management's portfolio value fell 3.1% quarter-over-quarter to $299M.

Based on Endurant Capital Management's 13F filing for Q2 2016, filed 15 Aug 2016.